BUSINESS● LOWJun 30 · Jun 30, 2026, 1:21 PM
Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value
Yahoo Finance
The price target for Nurix Therapeutics, Inc. (NRIX) has been raised due to the perceived value of its partnership with Roche. This indicates a positive financial outlook for the company based on its collaboration.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS14m agoInitial jobless claims unexpectedly fall in past week, continuing claims riseSeeking Alpha TechBUSINESS15m agoflatexDEGIRO SE reports Q3 resultsSeeking Alpha Tech